ILT3 binding molecules and uses therefor

Details for Australian Patent Application No. 2006261127 (hide)

Owner Tolerx, Inc.

Inventors Rao, Patricia; Ponath, Paul; Ponte, Jose F.; Smith, L. Mary; Rosenzweig, Michael

Agent FB Rice

Pub. Number AU-B-2006261127

PCT Pub. Number WO2006/138739

Priority 60/723,340 04.10.05 US; 60/691,912 17.06.05 US

Filing date 19 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 15 March 2012

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/138739 Priority application(s): WO2006/138739

15 March 2012 Application Accepted

  Published as AU-B-2006261127

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261132-Heteroaryl derivatives for treating viruses

2006261122-Pyrimidine derivatives for the treatment op GABA B mediated nervous system disorders